Law360, New York (January 5, 2018, 3:07 PM EST) — A question that affects where drugmakers can sue their generic competitors has split district courts following the U.S. Supreme Court’s landmark TC Heartland decision in May, likely giving rise to more fights over venue in cases involving abbreviated …